Exchange Traded Concepts, LLC Fate Therapeutics Inc Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 42,289 shares of FATE stock, worth $93,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,289

Previous 30,059 40.69%

Holding current value

$93,881

Previous $98,000 51.02%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$3.12 - $5.57 $38,157 - $68,121	12,230 Added 40.69%	42,289 $148,000
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $30,484 - $66,205	-9,351 Reduced 23.73%	30,059 $98,000
Q1 2024 Apr 15, 2024	SELL	$3.54 - $8.35 $86,075 - $203,030	-24,315 Reduced 38.16%	39,410 $289,000
Q4 2023 Jan 05, 2024	BUY	$1.65 - $3.94 $26,662 - $63,666	16,159 Added 33.97%	63,725 $238,000
Q3 2023 Oct 18, 2023	BUY	$2.02 - $5.04 $44,349 - $110,653	21,955 Added 85.72%	47,566 $100,000
Q2 2023 Jul 20, 2023	SELL	$4.76 - $6.59 $937,672 - $1.3 Million	-196,990 Reduced 88.49%	25,611 $121,000
Q1 2023 Apr 12, 2023	BUY	$4.24 - $11.12 $768,728 - $2.02 Million	181,304 Added 439.02%	222,601 $1.27 Million
Q4 2022 Jan 17, 2023	BUY	$9.86 - $23.83 $100,433 - $242,732	10,186 Added 32.74%	41,297 $417,000
Q3 2022 Oct 07, 2022	SELL	$21.04 - $36.06 $120,748 - $206,948	-5,739 Reduced 15.57%	31,111 $697,000
Q2 2022 Jul 20, 2022	BUY	$17.78 - $42.39 $45,979 - $109,620	2,586 Added 7.55%	36,850 $913,000
Q1 2022 Apr 26, 2022	BUY	$29.67 - $60.28 $132,476 - $269,150	4,465 Added 14.98%	34,264 $1.33 Million
Q4 2021 Jan 13, 2022	BUY	$47.84 - $64.34 $248,815 - $334,632	5,201 Added 21.14%	29,799 $1.74 Million
Q3 2021 Oct 18, 2021	BUY	$59.27 - $95.73 $1.46 Million - $2.35 Million	24,598 New	24,598 $1.46 Million
Q2 2021 Jul 30, 2021	SELL	$67.25 - $92.52 $137,122 - $188,648	-2,039 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$72.16 - $117.4 $656,872 - $1.07 Million	-9,103 Reduced 81.7%	2,039 $168,000
Q4 2020 Jan 19, 2021	SELL	$38.09 - $100.95 $259,697 - $688,277	-6,818 Reduced 37.96%	11,142 $1.01 Million
Q3 2020 Oct 30, 2020	BUY	$30.41 - $40.5 $546,163 - $727,380	17,960 New	17,960 $718,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Fate Therapeutics Inc Transaction History